The Economist on Friday published two articles from Saturday’s print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that “[f]ew areas of international affairs have seen more recent success than the fight against AIDS,” and discusses advancements in HIV treatment research and availability (7/28). A second article provides a recap of several studies presented at the conference, notes “some people are starting to look beyond [current] antiretroviral (ARV) drugs,” and writes, “Several clues suggest a cure may be possible” (7/28). In a related post, the Economist’s “Babbage” blog reports on new tuberculosis (TB) research presented at the conference on Monday, which “found that a combination of one experimental drug, one drug approved for other infectious diseases and one existing TB drug had a comparable effect to standard TB treatment,” suggesting “the combination may fight some TB strains resistant to other drugs — and do so quite quickly” (7/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.